TD Cowen reiterates Buy on O’Reilly Automotive stock on NAPA deal

O’Reilly Automotive (ORLY) is reportedly considering acquiring Genuine Parts’ NAPA auto parts business in a deal potentially exceeding $10B, with TD Cowen estimating accretion of ~16% in fiscal 2027 and ~19% in fiscal 2028 for the global automotive business (and ~5%/~9% for North America). The analyst flags valuation optics (ORLY at ~19.2x EV/EBITDA vs deal implied ~7–13x) and “strategy and operational” questions, pressuring shares to $83.42 near the 52-week low. Separately, the company approved a $2B increase to its share repurchase authorization to $31.75B, reinforcing shareholder-return capacity despite regulatory overhang noted by Barclays.

Analysis

The key market mechanism is not the headline accretion number, but whether ORLY is being forced into a step-up acquisition to defend network density and pro-channel share. If so, the near-term earnings lift could come with a higher leverage profile, integration risk, and a lower-quality growth narrative, which is exactly the kind of trade that looks great on a spreadsheet and then compresses the multiple when execution slips. In other words, this may be value-accretive but not valuation-accretive at 19x EBITDA if the market starts underwriting debt-funded inorganic growth instead of comp growth.

For competitors, the real pressure is on AAP and regional wholesalers: a larger ORLY footprint would likely intensify pricing and service competition in the Northeast/Mid-Atlantic, where route density and delivery speed matter more than headline store count. That can force weaker players to spend more on labor, inventory, and logistics just to hold share, which is bad for gross margin and working capital turns over the next 1-3 quarters. GPC, meanwhile, could get a cleaner balance-sheet story if the divestiture proceeds are used to simplify the remaining business, but only if the sale price is not forced by urgency.

The contrarian point is that the market may be overreacting to the possibility of a deal because the biggest variable is not synergy math, it is financing structure and regulatory scope. If ORLY pays with debt or equity at current valuation, the implied IRR can deteriorate quickly; if the deal stalls, the stock may rebound only if investors refocus on core share gains and buybacks. Falsifier: a disclosed purchase price materially below $10B, limited overlap scrutiny, or management guidance that confirms leverage stays near current levels; otherwise, assume the stock remains capped until more certainty emerges.

Key Decisions for Investors

• Watchlist, not immediate chase: ORLY into any deal confirmation. Only buy a post-announcement dip if financing is largely debt-free and synergies are explicitly cash-realizable within 12-18 months; otherwise the stock is vulnerable to multiple compression back toward low-teens EBITDA.
• Relative value: long GPC / short ORLY for 1-3 months into headline risk. Thesis is that GPC can monetize the separation without taking on integration risk, while ORLY absorbs execution and leverage uncertainty. Stop if ORLY announces highly accretive terms with limited debt load.
• If the spread widens on rumor-driven weakness, consider a tactical ORLY put spread 2-3 months out rather than stock shorting. You want downside exposure to deal disappointment or regulatory delay, with defined risk if management walks away and the core business rerates.
• Avoid chasing auto-parts beta until purchase price and funding are disclosed. The trade is catalyst-dependent; absent terms, the market is trading option premium, not fundamentals.
• Use AAP as a sector proxy short on confirmation of a larger ORLY footprint in pro channels. Time horizon: 1-6 months; invalidation would be evidence that overlap is minimal or that ORLY is forced to de-emphasize price aggressiveness.